Sacral Nerve Stimulation for Urinary Voiding Dysfunction, Fecal Incontinence and Constipation
Defines Cigna coverage policy for permanent sacral nerve stimulation (SNS) implantation and implantable tibial nerve stimulation for urinary voiding dysfunction and fecal incontinence, and states SNS is not medically necessary for constipation or other indications. Includes coding guidance and Medicare determinations.
Removed policy statement for screening trial of sacral nerve stimulation (SNS) for Urinary Voiding Dysfunction.
Removed policy statement for screening trial of sacral nerve stimulation for Fecal Incontinence.
Removed policy statement for Implantable Tibial Nerve Stimulation.
Title change.
Removed policy statement for percutaneous tibial nerve stimulation (PTNS) maintenance therapy and number of treatments allowed.